Clinical Trials in Changsha, China
Locations / Changsha, China
Delta Trials records 3,335 clinical trials conducted in Changsha, China, making it a notable site of clinical research activity. These trials across 2,326 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 141 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Changsha has changed over time.
3335
Total Trials
2326
Conditions
141
Terminated since 2020
Browse by condition (2326 total)
- Non-small cell lung cancer 169 trialsAll Non-small cell lung cancer trials
- Breast cancer 59 trialsAll Breast cancer trials
- Advanced solid tumor 47 trialsAll Advanced solid tumor trials
- Schizophrenia 44 trialsAll Schizophrenia trials
- Hepatocellular carcinoma 34 trialsAll Hepatocellular carcinoma trials
- Asthma 34 trialsAll Asthma trials
- Atopic dermatitis 33 trialsAll Atopic dermatitis trials
- Gastric cancer 32 trialsAll Gastric cancer trials
- Carcinoma, non-small-cell lung 30 trialsAll Carcinoma, non-small-cell lung trials
- Type 2 diabetes mellitus 30 trialsAll Type 2 diabetes mellitus trials
- Ovarian cancer 29 trialsAll Ovarian cancer trials
- Advanced solid tumors 27 trialsAll Advanced solid tumors trials
- Chronic hepatitis b 23 trialsAll Chronic hepatitis b trials
- Prostate cancer 22 trialsAll Prostate cancer trials
- Diabetes mellitus, type 2 22 trialsAll Diabetes mellitus, type 2 trials
- Small cell lung cancer 22 trialsAll Small cell lung cancer trials
- Breast neoplasms 21 trialsAll Breast neoplasms trials
- Heart failure 21 trialsAll Heart failure trials
- Solid tumor 21 trialsAll Solid tumor trials
- Crohn's disease 20 trialsAll Crohn's disease trials